Story
Bavarian Nordic Shares Climb on Appointment of Pharma Veteran Tarja Stenvall as CEO
Summary
Danish vaccine maker Bavarian Nordic has named Tarja Stenvall, an executive with over two decades of experience at Pfizer and AstraZeneca, as its new President and CEO, sending its shares up 2.5%.
Shares of Bavarian Nordic rose 2.5% on Thursday after the Danish vaccine maker announced the appointment of pharmaceutical industry veteran Tarja Stenvall as its new President and Chief Executive Officer. Stenvall is set to succeed Paul Chaplin, whose departure was previously announced, effective October 15.
New Leadership Details
The company's Board Chair, Anne Louise Eberhard, stated that Stenvall was selected following a "comprehensive search." The decision was based on her extensive experience leading global life sciences businesses and her deep background in both pharmaceuticals and vaccines.
Stenvall brings a significant track record to the role, with more than 20 years of leadership experience at major pharmaceutical companies. Her career includes holding country, regional, and global positions at:
- Sanofi
- AstraZeneca
- Pfizer
AdHer expertise spans specialty care, general medicines, and vaccines, providing a broad foundation for her new leadership position at Bavarian Nordic.
Strategic Focus and Transition
In a statement, Stenvall said she was "tremendously excited" to join the company, highlighting its scientific foundation and global manufacturing and commercial platforms. She outlined her initial focus on expanding the global reach of Bavarian Nordic's vaccines and strengthening its overall position in the global vaccine market.
Eberhard also thanked outgoing CEO Paul Chaplin for his years of service, crediting him with helping to transform Bavarian Nordic from a research-focused entity into a commercial-stage, global vaccines business.
Read next
More on Stocks
US Mortgage Rates Climb for Fourth Week, Approaching 7% Threshold
The average 30-year fixed mortgage rate has risen to 6.95%, its highest level since early 2023, following a recent Federal Reserve rate hike and further straining housing affordability.
U.S. Stock Futures Ease After Wall Street Rallies on Softer Yields, Oil Prices
U.S. stock futures edged lower in overnight trading, taking a breather after a strong market rally on Thursday. The gains were driven by a drop in both Treasury yields and crude oil prices following the Federal Reserve's latest interest rate decision.
U.S. Stocks Climb as Surprise Drop in Jobless Claims Boosts Tech Sector
Major U.S. indices closed higher on Thursday after a surprise drop in weekly jobless claims pointed to a resilient labor market, fueling a rally in technology and semiconductor stocks.
Musk's AI Unit Considers Buying Data from Bankrupt Startups to Train Grok, Sources Say
Elon Musk's artificial intelligence unit, SpaceXAI, is reportedly in early discussions to purchase customer and operational data from failed or struggling companies to enhance its AI models, according to people familiar with the matter.